nLite 360® - AI Gen 2

nLite 360® – AST I3

nLite360® – BST I3

nlitePad

About Us

Neonatal Jaundice

Globally, Healthcare providers worldwide recognize that severe neonatal jaundice is a “silent” cause of significant neonatal morbidity and mortality.
01.

New born baby care

02.

nLite your baby health

black-arrow Know More

Over 60% of all newborns develop neonatal jaundice

56 +

Around 15% to 45% of newborns develop severe neonatal jaundice in developing countries

360 +

Around 10% of newborns die due to neonatal jaundice all over the world

89 K

Almost 20% of the jaundice babies in india alone ,die due to severe neonatal jaundice

42 +

Our Solutions

High Quality Solutions
for new born babies.

Introducing A smart Design approached technology
A Revolutionary Phototherapy device for neonatal jaundice management.

Challenges

Current
Treatment Challenges

SLOW TREATMENT
01

SLOW TREATMENT

Existing treatments result in a prolonged 2-3 week delay, impacting timely care for infants.
SEVERE JAUNDICE CONDITION
02

SEVERE JAUNDICE CONDITION

Blood transfusion and current indigenous methods fall short in effectively addressing severe jaundice cases.
POST-NATAL SEPARATION
03

POST-NATAL SEPARATION

Immediate separation after birth causes anxiety and disrupts the crucial initial bond between newborns and mothers.
LOW EFFICIENCY
04

LOW EFFICIENCY

Treatment efficiency is hindered by factors such as suboptimal irradiance, inadequate body surface exposure, and insufficient breastfeeding.

Home Phototherapy

Neonatal care at your Doorstep From an IIT Hyderabad startup

*Ensuring Newborn Joy under Expert Guidance

People Trusted

Our Partnering Doctor

DR. SWAPNA. LINGALDINNA


Associate PROFESSOR OF NEONATOLOGY NILOUFER HOSPITAL, HYDERABAD.

“I’m thrilled to partner with HEAMAC! Their innovative phototherapy devices have significantly improved newborn care, and I’m proud to be part of this journey.”

Heamac

Supported By

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

The feedback system delivers the optimal level of irradiance, while the portable version allows treatment to be administered directly in the mother's ward.

Dr. Swapna

Neonatologist, Neloupher Maternal and Children Govt. Hospital.

The device features triple-surface phototherapy, minimizing heat and dehydration for the baby. Additionally, its adjustable irradiance levels allow for quicker reduction of jaundice and help prevent the need for blood transfusions

Dr. Alimelu, HOD

Neonatology Dept. Neloupher Maternal and Children Govt. Hospital, Prof. Neonatology Osmania Medical College.

The product supports both standalone and portable versions, making it suitable for treating critical cases in the NICU as well as providing home-based care for babies with mild jaundice.

Dr. Suresh

Peidtaician, DCH, MBBS, Neloupher Maternal and Children Hospital

The device is lightweight with a sleek design, ensuring comfort during breastfeeding and Kangaroo Mother Care. Its battery-powered mode makes it ideal for use in rural Primary Healthcare Centers (PHCs).

Dr. Bezawada Prasanth Babu

Pediatrition, DCH, MBBS Kamineni hospitals, Hyderabad.

I recommend HEAMAC Phototherapy as it provides continuous therapy while automatically adjusting the intensity to prevent over or undertreatment.

Dr. Manoj Kumar

Neonatologist, Vellamal Hospital, Madurai.

The intelligent feedback module enables effective treatment in remote areas, even with low-skilled staff.

Dr.Srinivas Murki

(Paediatrician) Fernandez Children Hospital, Hyderabad.

Heamac

Our Clients

1
2
3

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Phone Icon WhatsApp Icon Appointment Icon